How does teriparatide compare with alendronate for the treatment of glucocorticoid-induced osteoporosis?

  • René Rizzoli
  • Published 2008 in
    Nature Clinical Practice Endocrinology…

Abstract

DESIGN AND INTERVENTION This was an 18-month, international, doubleblind, randomized, placebo-controlled trial of teriparatide versus alendronate. Inclusion criteria included age ≥21 years, history of glucocorticoid therapy (mean daily dose of ≥5 mg of prednisone or its equivalent for ≥3 consecutive months), and lumbar spine or total hip BMD of ≤–2 SD or… (More)
DOI: 10.1038/ncpendmet0838

Topics

  • Presentations referencing similar topics